Australia markets closed

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
40.930.00 (0.00%)
At close: 01:26PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 8.47B
Enterprise value 9.91B
Trailing P/E 28.04
Forward P/E 18.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.44
Price/book (mrq)6.10
Enterprise value/revenue 5.83
Enterprise value/EBITDA 18.04

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 3-36.01%
S&P500 52-week change 3-9.85%
52-week high 363.96
52-week low 336.00
50-day moving average 340.32
200-day moving average 340.52

Share statistics

Avg vol (3-month) 335
Avg vol (10-day) 3N/A
Shares outstanding 5205.4M
Implied shares outstanding 6N/A
Float 897.17M
% held by insiders 151.82%
% held by institutions 125.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.13
Forward annual dividend yield 42.77%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 32.74%
5-year average dividend yield 4N/A
Payout ratio 469.44%
Dividend date 3N/A
Ex-dividend date 420 Nov 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 18.38%
Operating margin (ttm)28.75%

Management effectiveness

Return on assets (ttm)9.37%
Return on equity (ttm)21.67%

Income statement

Revenue (ttm)1.8B
Revenue per share (ttm)8.75
Quarterly revenue growth (yoy)25.90%
Gross profit (ttm)1.15B
EBITDA 622.84M
Net income avi to common (ttm)331.04M
Diluted EPS (ttm)1.73
Quarterly earnings growth (yoy)0.80%

Balance sheet

Total cash (mrq)346.61M
Total cash per share (mrq)1.69
Total debt (mrq)1.72B
Total debt/equity (mrq)106.85
Current ratio (mrq)1.60
Book value per share (mrq)7.83

Cash flow statement

Operating cash flow (ttm)485.2M
Levered free cash flow (ttm)151.59M